Login to Your Account

Analyst: 'Wow. Just wow'

The phase III win in March testing oral CFTR corrector tezacaftor and approved CFTR potentiator Kalydeco in CF patients left investors and analysts predicting success in early stage testing for triple-combo regimens featuring ivacaftor, tezacaftor and one of four possible next-generation CF correctors. more »

Our Habitat for All Things Science
Clearing senescent cells, restoring progenitor stem cells to reverse age-related disease

SAN DIEGO – Nobody wants to get old. Health declines, disease increases and insurance costs skyrocket. But what if researchers could slow the process at the cellular level, reverting stem cells to their youthful state, or clearing senescent cells, a hallmark of advanced years?

Two companies working in the space presented their research at the BIO convention during a session titled "Reimagine Old Age: New Frontiers in the Science of Aging."

The aging process involves a loss of homeostasis, with messy DNA and reduced gene expression.READ MORE »


Partners in Focus